FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4322752849> ?p ?o ?g. }

• W4322752849 endingPage "58" @default.
• W4322752849 startingPage "52" @default.
• W4322752849 abstract "Introduction. Chemotherapy with Cabazitaxel (CBZ) is a typical first-line treatment option for naïive castration-resistant prostate cancer resistant to docetaxel. On the other hand, Cabazitaxel's therapeutic success is constrained by chemoresistance and side effects. Aim. To assess whether 6 alpha-ethylchenodeoxycholic acid (6-ECDCA), a selective agonist for bile acid receptors will enhance the efficacy of CBZ in androgen-independent prostate cancer cells. Materials and methods. The 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) viability assay was used to assess the cytotoxicity of 6-ECDCA and CBZ medicines or their combinations against the human prostate cancer cell line (PC-3). The combination outcome suggested by Chou TC et al. was then evaluated using the combination index (CI) to find out the nature of synergism, antagonism, and additive effect of the drug’s combination. Furthermore, the Dose-Reduction Index (DRI) was determined to measure how many times the dose could be reduced for each drug in a synergistic combination. Results and discussion. Analysis of the dose-effect curve showed that the treatment of PC-3 cells with CBZ alone or combined with 6-ECDCA for 48 h led to 50 % cytotoxicity of 20.5 nM and 4.7 nM, respectively. 6-ECDCA at 1.77 µM had an additive effect based on the CI value, which was 1.02, while at 21.02 µM, the CI was 0.54 which designates a strong synergistic effect. The combination of CBZ and 6-ECDCA at a submaximal lower dose by 6-folds of each one produced a 95 % cell death than treatment with either agent alone. Conclusion. The Combination index plot showed CI ≤ l for all combinations used in this study, which indicates additive and synergistic interactions between CBZ and 6-ECDCA. The significant impact of 6-ECDCA in combination with CBZ for treating androgen-independent prostate cancer cells was confirmed by this study to be preferred to the treatment with a single drug." @default.
• W4322752849 created "2023-03-03" @default.
• W4322752849 creator A5045761713 @default.
• W4322752849 creator A5047509270 @default.
• W4322752849 creator A5051763235 @default.
• W4322752849 date "2023-02-27" @default.
• W4322752849 modified "2023-10-06" @default.
• W4322752849 title "Cytotoxic Effect of 6-Ethyl-Chenodeoxycholic Acid and Cabazitaxel on PC-3 Cells" @default.
• W4322752849 cites W135020787 @default.
• W4322752849 cites W1966721756 @default.
• W4322752849 cites W1973798901 @default.
• W4322752849 cites W1986508603 @default.
• W4322752849 cites W1992138428 @default.
• W4322752849 cites W2049515100 @default.
• W4322752849 cites W2072917822 @default.
• W4322752849 cites W2090652850 @default.
• W4322752849 cites W2126600663 @default.
• W4322752849 cites W2141724777 @default.
• W4322752849 cites W2151241358 @default.
• W4322752849 cites W2342609081 @default.
• W4322752849 cites W2518389324 @default.
• W4322752849 cites W2529653456 @default.
• W4322752849 cites W2580727400 @default.
• W4322752849 cites W2751987408 @default.
• W4322752849 cites W2760388735 @default.
• W4322752849 cites W2766982721 @default.
• W4322752849 cites W2807183240 @default.
• W4322752849 cites W2883359071 @default.
• W4322752849 cites W2883810275 @default.
• W4322752849 cites W2900774558 @default.
• W4322752849 cites W2909500496 @default.
• W4322752849 cites W2939109551 @default.
• W4322752849 cites W2943839145 @default.
• W4322752849 cites W2977732097 @default.
• W4322752849 cites W2982336473 @default.
• W4322752849 cites W3003103377 @default.
• W4322752849 cites W3016612641 @default.
• W4322752849 cites W3023823430 @default.
• W4322752849 cites W3036213667 @default.
• W4322752849 cites W3088838661 @default.
• W4322752849 cites W3098159948 @default.
• W4322752849 cites W3122946735 @default.
• W4322752849 cites W3155786829 @default.
• W4322752849 cites W3213072219 @default.
• W4322752849 cites W4212975902 @default.
• W4322752849 cites W4282964224 @default.
• W4322752849 cites W4283216667 @default.
• W4322752849 doi "https://doi.org/10.33380/2305-2066-2023-12-1-52-58" @default.
• W4322752849 hasPublicationYear "2023" @default.
• W4322752849 type Work @default.
• W4322752849 citedByCount "0" @default.
• W4322752849 crossrefType "journal-article" @default.
• W4322752849 hasAuthorship W4322752849A5045761713 @default.
• W4322752849 hasAuthorship W4322752849A5047509270 @default.
• W4322752849 hasAuthorship W4322752849A5051763235 @default.
• W4322752849 hasBestOaLocation W43227528491 @default.
• W4322752849 hasConcept C109316439 @default.
• W4322752849 hasConcept C121608353 @default.
• W4322752849 hasConcept C126322002 @default.
• W4322752849 hasConcept C170493617 @default.
• W4322752849 hasConcept C185592680 @default.
• W4322752849 hasConcept C19831878 @default.
• W4322752849 hasConcept C202751555 @default.
• W4322752849 hasConcept C2777383412 @default.
• W4322752849 hasConcept C2777511904 @default.
• W4322752849 hasConcept C2777899217 @default.
• W4322752849 hasConcept C2778971682 @default.
• W4322752849 hasConcept C2780035454 @default.
• W4322752849 hasConcept C2780192828 @default.
• W4322752849 hasConcept C2781190966 @default.
• W4322752849 hasConcept C530470458 @default.
• W4322752849 hasConcept C55493867 @default.
• W4322752849 hasConcept C61367390 @default.
• W4322752849 hasConcept C71924100 @default.
• W4322752849 hasConcept C98274493 @default.
• W4322752849 hasConceptScore W4322752849C109316439 @default.
• W4322752849 hasConceptScore W4322752849C121608353 @default.
• W4322752849 hasConceptScore W4322752849C126322002 @default.
• W4322752849 hasConceptScore W4322752849C170493617 @default.
• W4322752849 hasConceptScore W4322752849C185592680 @default.
• W4322752849 hasConceptScore W4322752849C19831878 @default.
• W4322752849 hasConceptScore W4322752849C202751555 @default.
• W4322752849 hasConceptScore W4322752849C2777383412 @default.
• W4322752849 hasConceptScore W4322752849C2777511904 @default.
• W4322752849 hasConceptScore W4322752849C2777899217 @default.
• W4322752849 hasConceptScore W4322752849C2778971682 @default.
• W4322752849 hasConceptScore W4322752849C2780035454 @default.
• W4322752849 hasConceptScore W4322752849C2780192828 @default.
• W4322752849 hasConceptScore W4322752849C2781190966 @default.
• W4322752849 hasConceptScore W4322752849C530470458 @default.
• W4322752849 hasConceptScore W4322752849C55493867 @default.
• W4322752849 hasConceptScore W4322752849C61367390 @default.
• W4322752849 hasConceptScore W4322752849C71924100 @default.
• W4322752849 hasConceptScore W4322752849C98274493 @default.
• W4322752849 hasIssue "1" @default.
• W4322752849 hasLocation W43227528491 @default.
• W4322752849 hasOpenAccess W4322752849 @default.
• W4322752849 hasPrimaryLocation W43227528491 @default.

• next